Field Medical | $35,000,000 | (Jul 2, 2025)
Syntis Bio | $38,000,000 | (Jul 2, 2025)
Deeto | $12,500,000 | (Jul 2, 2025)
Certified by Founder
Lodge
Moonwalk Biosciences
start up
United States
- South San Francisco, California
- 08/01/2024
- Series A
- $57,000,000
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
- Industry Biotechnology Research
- Website https://moonwalk.bio/
- LinkedIn https://www.linkedin.com/company/moonwalk-biosciences/about/
Talon.One | $135,000,000 | (Jul 2, 2025)
Bonx | $8,600,000 | (Jul 2, 2025)
Civ Robotics | $7,500,000 | (Jul 2, 2025)
Metafide | $3,275,000 | (Jul 2, 2025)
Genesis AI | $105,000,000 | (Jul 2, 2025)
Emerald AI | $24,500,000 | (Jul 2, 2025)
zango | $4,800,000 | (Jul 2, 2025)
Clearspeed | $60,000,000 | (Jul 1, 2025)
Foresight(US) | $5,500,000 | (Jul 1, 2025)